Chemical Compound

(3E,5S,8R,9S,10R,13S,14S)-3-(2-azanylethoxyimino)-10,13-dimethyl-1,2,4,5,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-6,17-dione

CAS Registry Number 203737-93-3
(3E,5S,8R,9S,10R,13S,14S)-3-(2-azanylethoxyimino)-10,13-dimethyl-1,2,4,5,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-6,17-dione 结构式
Primary record

(3E,5S,8R,9S,10R,13S,14S)-3-(2-azanylethoxyimino)-10,13-dimethyl-1,2,4,5,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-6,17-dione

库存
3,196 克
纯度
98.1 %
CAS
203737-93-3

化合物标识与属性

CAS
203737-93-3
PubChem CID
9841834
SMILES
C[C@]12CC/C(=N\OCCN)/C[C@@H]1C(=O)C[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC4=O)C
Canonical SMILES
C[C@]12CC/C(=N\OCCN)C[C@@H]1C(=O)C[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12

名称与同义词

  • Istaroxime
  • istaroximum
  • Istaroxima
  • Istaroxime [INN]
  • E-Istaroxime
  • Istaroxime, (E)-
  • Debio-0614
  • (E,Z)-Istaroxime
  • PST-2744
  • UNII-W8I9H2TPPL
  • W8I9H2TPPL
  • 203737-93-3
  • Istaroxime(PST2744)
  • RefChem:792461
  • D06HIO
  • PST2744
  • CHEMBL469045
  • PST 2744
  • UNII-W40687GO3S
  • orb1707170
  • SCHEMBL7285904
  • W40687GO3S
  • EX-A1517E
  • DTXSID20870222
  • PST2774
  • C21H32N2O3
  • PST-2107
  • PST-2915
  • ST-2744
  • Digitalis-like compounds, Sigma-Tau
  • BDBM50605867
  • MFCD26142936
  • AKOS024259258
  • ACN-052464
  • CID9841834
  • CS-1531
  • DB06157
  • AC-36855
  • AS-78198
  • DA-74601
  • HY-15718
  • 3-((2-Aminoethoxy)imino)-5alpha-androstan-6,17-dione
  • W-6141
  • (3E,5S,8R,9S,10R,13S,14S)-3-(2-aminoethoxyimino)-10,13-dimethyl-1,2,4,5,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-6,17-dione
  • 203738-46-9
  • 3-((2-Aminoethoxy)imino)androstane-6,17-dione
  • 5-alpha-Androstan-6,17-dione, 3-((2-aminoethoxy)imino)-
  • Q4204315
  • BRD-K95412502-003-01-5
  • (3E)-3-[(2-Aminoethoxy)imino]-5alpha-androstane-6,17-dione
  • Na(+)-/K(+)-ATPase inhibitors (cardiac failure), Sigma-Tau
  • 203737-94-4
  • Androstane-3,6,17-trione, 3-(O-(2-aminoethyl)oxime), (3E,5alpha)-
  • ANDROSTANE-3,6,17-TRIONE, 3-(O-(2-AMINOETHYL)OXIME), (3E,5.ALPHA.)-
  • Na(+)-/K(+)-ATPase inhibitors (infusion, cardiac failure), Sigma-Tau/ Debiopharm
  • Sodium/potassium-ATPase inhibitors (infusion, cardiac failure), Sigma-Tau/Debiopharm
  • (3aS,3bR,5aS,7E,9aR,9bS,11aS)-7-((2-aminoethoxy)imino)-9a,11a-dimethyl-hexadecahydro-1H-cyclopenta(a)phenanthrene-1,5-dione
  • (3E,5S,8R,9S,10R,13S,14S)-3-(2-azanylethoxyimino)-10,13-dimethyl-1,2,4,5,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-6,17-dione
  • (5S,8R,9S,10R,13S,14S,E)-3-((2-aminoethoxy)imino)-10,13-dimethyltetradecahydro-1H-cyclopenta[a]phenanthrene-6,17-dione